SCHEMBL24997019

SCHEMBL24997019

CCCN1CCCC12CCC2

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.30
SOS2 Q07890 1/20 0.30
BDKRB2 P30411 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22080770 0.95 SOS1 (0.34) SOS1SOS2BDKRB2
SCHEMBL19336780 0.85 GNAI3 (0.34)
SCHEMBL25701498 0.83
SCHEMBL26846516 0.81 BDKRB2 (0.33) BDKRB2
SCHEMBL19121218 0.80 ROCK2 (0.32)
SCHEMBL24577848 0.76 ALOX15 (0.36)
SCHEMBL9286726 0.76 BDKRB2 (0.30) BDKRB2
SCHEMBL19121494 0.75 ROCK2 (0.34) SOS1SOS2
SCHEMBL19120916 0.75
Hydrochloric Acid SCHEMBL30203016 0.74 ALOX15 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023015240-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS FOR USE AS HER2 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-02-09 WO disclosed